Latest Breaking News On - பிரியா - Page 8 : comparemela.com
Peligros e incógnitas de la cepa doble mutante india
lasexta.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lasexta.com Daily Mail and Mail on Sunday newspapers.
Triple mutant strain: 60% of Indian variant samples tested in labs found in Maharshtra
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Share
New Delhi: In the backdrop of reports of emergence of variants of the SARS-CoV-2, in the UK and some other parts of the world, the Government of India had established a national multi-agency consortium, Indian SARS-CoV-2 Genomic Consortium (INSACOG) in December 2020, consisting of ten laboratories of the
Department of Biotechnology,
Council of Scientific and Industrial Research (CSIR),
Indian Council of Medical Research (ICMR) and Ministry of Health & Family Welfare (MoHF&W) with the overall aim of monitoring the genomic variations in the SARS-CoV-2 on a regular basis. The responsibility to correlate the clinical aspects and coordinate the collection of samples from states, for this purpose, was provided to
April 23, 2021
Experts believe that 98-99% assays can pick up all the strains of virus
RT-PCR continues to be the gold standard for Covid-19 diagnosis with 98-99 per cent of assays used in the country picking up the virus, Priya Abraham, Director of the Pune-based National Institute of Virology (NIV), an Indian Council of Medical Research constituent lab, said on Friday. If this diagnostic test was throwing up false negatives, as reported in a section of the media, that could be either because of inappropriate sampling or compromised integrity of reagents, she said.
In the extremely stressful situation in a clinical setting, sampling may be inappropriate, individuals may be appearing late for sampling, or improper transportation of the kits can lead to loss of the integrity of enzymes used for the RT-PCR test, she said. Abraham and a few other experts were participating in a webinar on SARS-Cov2 mutants, organised by the National Biopharma Mission.
Updated:
Proportion has risen from 28% in March to 50% last week in genome sequencing.
Share Article
AAA
COVID-19 patients wait to get admitted outside the casualty ward at Guru Teg Bahadur hospital in New Delhi on April 23, 2021. | Photo Credit:
REUTERS
Proportion has risen from 28% in March to 50% last week in genome sequencing.
The proportion of the U.K. variant (B.1.1.7) in genome samples sequenced from COVID cases in Delhi has risen from 28% in the second week of March to the 50% in the last week, Dr. Sujeet Singh, Director, National Centre for Disease Control (NCDC) said in a webinar on Friday.
The U.K. variant has a mutation N501Y that is reported to increase the transmission of the virus leading to more numbers and a knock-on consequence of increasing disease severity and mortality.
vimarsana © 2020. All Rights Reserved.